|
2 Companies |
|
2 Products |
|
2 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
12 News |
|
- | NN1213 / Novo Nordisk
Trial completion: Clinical Evaluation of Silk'n Glide for Face (clinicaltrials.gov) - Sep 10, 2018
P=N/A, N=17, Completed, Sponsor: Home Skinovations Ltd.
Active, not recruiting --> Completed
- | Trial completion: Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth (clinicaltrials.gov) - Aug 1, 2017
P1/2, N=44, Completed, Sponsor: Follicum AB
Active, not recruiting --> Completed Recruiting --> Completed
- | isotretinoin / Generic mfg.
New P4 trial: Effects of Isotretinoin on The Gonads and Hirsutism (clinicaltrials.gov) - Aug 4, 2016
P4, N=80, Completed, Sponsor: Kayseri Education and Research Hospital
- New P1/2 trial: Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth (clinicaltrials.gov) - Jun 9, 2016
P1/2, N=40, Recruiting, Sponsor: Follicum AB
- Clinical: Clinical Evaluation of Silk'n Glide for Face (clinicaltrials.gov) - Apr 2, 2014
P=N/A, N=16, Active, not recruiting, Sponsor: Home Skinovations Ltd.
- Enrollment change: A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=2, Terminated, Sponsor: Corcept Therapeutics
Recruiting --> Completed N=150 --> 2
- eflornithine topical / Generic mfg.
Trial completion: Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism (clinicaltrials.gov) - Nov 28, 2013
P4, N=22, Completed, Sponsor: Bispebjerg Hospital
N=150 --> 2 Recruiting --> Completed
- Enrollment change: Obesity and Clinical Presentation of Hyperandrogenism (clinicaltrials.gov) - Nov 3, 2013
P=N/A, N=46, Completed, Sponsor: Taipei Medical University WanFang Hospital
Recruiting --> Completed N=100 --> 46
- eflornithine topical / Generic mfg.
New P4 trial: Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism (clinicaltrials.gov) - Mar 24, 2013
P4, N=22, Completed, Sponsor: Bispebjerg Hospital
- || Korlym (mifepristone) / Corcept Therap
Trial completion: SEISMIC: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome (clinicaltrials.gov) - Oct 20, 2011
P3, N=50, Completed, Sponsor: Corcept Therapeutics
N=100 --> 46 Active, not recruiting --> Completed
- Trial completion: Obesity and Clinical Presentation of Hyperandrogenism (clinicaltrials.gov) - Oct 10, 2011
P=N/A, N=46, Completed, Sponsor: Taipei Medical University WanFang Hospital
Active, not recruiting --> Completed Recruiting --> Completed